New graded prognostic index (GPI) for melanoma patients with brain metastasis (MBM).

被引:0
|
作者
Venur, Vyshak Alva
Sakruti, Susmita
Du, Lingling
Randhawa, Jaskirat Singh
Agwa, Eberechi Sandra
Murphy, Erin Sennett
Yu, Jennifer
Chao, Samuel T.
Suh, John H.
Elson, Paul
Angelov, Lilyana
Ahluwalia, Manmeet Singh
机构
[1] Cleveland Clin, Fairview Hosp, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] Cleveland Clinic Fairview, Cleveland, OH USA
[5] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9089
引用
收藏
页数:1
相关论文
共 50 条
  • [32] Prognostic factors for postoperative survival in melanoma patients with bone metastasis
    Wang, Yucheng
    Ren, Shihong
    Gong, Xiaokang
    Wang, Jiacheng
    Zhu, Ning
    Cai, Danyang
    Ruan, Jianwei
    MEDICINE, 2021, 100 (04)
  • [33] The prognostic utility of LDH and disease-specific graded prognostic assessment for melanoma brain metastases.
    Lowe, M.
    Cavitt, A.
    Shelton, J.
    Maynard, N.
    Crocker, I. R.
    Carlson, G. W.
    Delman, K. A.
    Lawson, D. H.
    Rizzo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Outcomes of patients with melanoma brain metastases (MBM) treated with standard of care therapy after being excluded from MBM-specific clinical trials
    Holbrook, K.
    Shephard, M. P.
    Haydu, L.
    Oliva, I. Glitza
    Amaria, R. N.
    Patel, S.
    Diab, A.
    Hwu, P.
    Brown, C.
    Arnold, I. Boesch
    Burton, E.
    Davies, M. A.
    Tawbi, H. A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [35] Serum S100B, Lactate Dehydrogenase and Brain Metastasis Are Prognostic Factors in Patients with Distant Melanoma Metastasis and Systemic Therapy
    Weide, Benjamin
    Richter, Sabina
    Buettner, Petra
    Leiter, Ulrike
    Forschner, Andrea
    Bauer, Juergen
    Held, Laura
    Eigentler, Thomas Kurt
    Meier, Friedegund
    Garbe, Claus
    PLOS ONE, 2013, 8 (11):
  • [36] Circulating tumor DNA mutation as a prognostic marker in melanoma with brain metastasis.
    Behera, Tapas Ranjan
    Song, Jung Min
    Eicher, Donald Matthew
    Gastman, Brian
    Farkas, Daniel H.
    Funchain, Pauline
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease
    James E. Bates
    Paul Youn
    Kenneth Y. Usuki
    Kevin A. Walter
    Christine F. Huggins
    Paul Okunieff
    Michael T. Milano
    Journal of Neuro-Oncology, 2015, 125 : 411 - 418
  • [38] Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC
    Yamamoto, Masaaki
    Serizawa, Toru
    Sato, Yasunori
    Higuchi, Yoshinori
    Kikuchi, Yasuhito
    Sato, Sonomi
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 48
  • [39] Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease
    Bates, James E.
    Youn, Paul
    Usuki, Kenneth Y.
    Walter, Kevin A.
    Huggins, Christine F.
    Okunieff, Paul
    Milano, Michael T.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 125 (02) : 411 - 418
  • [40] A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma
    S L Morris
    S H Low
    R P A'Hern
    T G Eisen
    M E Gore
    C M Nutting
    K J Harrington
    British Journal of Cancer, 2004, 91 : 829 - 833